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Abstract 
Given the prevalence of breast cancer, the mortality of patients and the public’s convenient 
access to the herbal extract of milk thistle, we decided to examine the effectiveness of this plant’s 
components on the breast cancer cell line MCF-7. Silibinin is a naturally occurring flavonoid 
antioxidant found in the milk thistle. Recently, it has demonstrated potent, anti-proliferative effects 
against various malignant cell lines. In the present study, MCF-7 cells were incubated and treated 
with various concentrations of silibinin repeatedly. The degree of cell cytotoxicity depended on the 
dose of the milk thistle’s extract and also on the duration of its exposure, imparting an inhibitory 
effect on the viability of metastatic MCF-7 cells. Finally, the expression of apoptotic genes (BCL-2 
and BAX) was assessed by Real time PCR. Cell viability and growth of MCF-7 cell lines were 
inhibited by silibinin. The results of the present study confirm the efficacy of the herbal supplement 
against breast cancer. Due to the nature of the product, its low cost and potential accessibility to the 
public, adding this herbal supplement to the human food diet may be effective in preventing and 
treating breast cancer. 
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Introduction 
Breast cancer is a common malignant neoplasm in women and is considered as the main 
cause of death in women (Fisch et al, 2005; Bray, McCarron, & Parkin, 2004). Chemotherapy is a 
cancer treatment method or temporary manner of relief via the use of certain medications .Side 
effects of chemotherapy depend on dosage. It can also lead to tumor recurrence and often lead to 
drug resistance (Hale et al, 2005; Juzenas, et al, 2008). It is understood that the consumption of 
some food products can be effective in preventing cancer due to antioxidant properties (Namiki, 
1990). Among these products, we can point to silymarin –– obtained from milk thistle seeds –– 
which has about 90% of its components allocated to the compound sili, binin (Deep & Agarwal, 
2010). 
Silibinin is a polyphenolic flavonoid which is commonly isolated from the fruits or seeds of 
the milk thistle (Silybum marianum); silymarin is a flavonolignan complex, composed of silibinin 
and small amounts of isosilybin A, isosilybin B, silychristin, iso-silychristin, dehydrosilybin, 
silydianin and taxifolin (Gazak et al, 2007). Silibinin has anticancer properties against many cancers 
including lung (Chu et al, 2004), skin (Mohan et al, 2004), bladder (Tyagi et al, 2004), liver 
(Momeny et al, 2008), prostate (Singh and Agarwal, 2004) and colon (Gazak et al, 2007) cancer 
cells. 
Silibinin induces apoptosis by down-regulation, providing for the inhibition of hypoxia-
inducible factor-1 alpha in non-small-cell lung cancer cells (Kim et al, 2010). Silibinin up-regulates 
the expression of cyclin-dependent kinase inhibitors and causes a cell cycle arrest. It also causes a 
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type of apoptosis which is independent of caspases’ activation in the human colon carcinoma HT-29 
cells (Agarwal et al, 2004). 
The Bcl-2 family of proteins regulates apoptosis, cell cycle and differentiation. Bcl-2 
proteins can inhibit the mitochondrial apoptotic pathway via binding to its pro-apoptotic protein 
Bax, thereby preventing the release of cytochrome c and the activation of the apoptotic cascade 
(Teijido & Dejean, 2010). Bax promotes apoptosis, induces permeabilization of the outer 
mitochondrial membrane (OMM), controls transition of cytochrome c through the OMM and 
maintains Ca2+ levels of the Endoplasmic Reticulum (Hoppins et al, 2011). 
The purpose of this study was to develop an understanding of silibinin’s effects on breast 
cancer cells and also determine its therapeutic value in preventing or treating this disease. Therefore, 
we examined the anticancer activities of silibinin against the MCF-7 breast cancer cell line. 
Materials and Methods 
Cell culture and Silibinin treatment 
MCF-7 cells were obtained from the National Cell Bank of Iran (NCBI), Pasteur Institute of 
Iran. MCF-7 cells were cultured on the RPMI-1640 medium, supplemented with 10% heat-
inactivated fetal calf serum (FCS), 2 mM glutamine, penicillin (100 IU/ml) and streptomycin (100 
mg/ml). Apart from the cell lines, the other materials were from Gibco, Scotland. The complex was 
maintained at 37⁰ C in an incubator containing 5% CO2. Harvested cells with trypsin (0.25%) 
(Sigma, USA) were counted by a Neobar slide with trypan blue and were then seeded into 96-well 
plates (1 * 104 cells/well). Silibinin (Sigma, USA) was dissolved in DMSO (Sigma, USA). The cells 
were incubated with different concentrations of silibinin (50, 100, 200mg/ ml) at 12, 24 and 48 
hours. A group of cells were not treated with silibinin. These were used as a negative control group 
of cells. All experiments were repeated three times. 
Measurement of cell viability 
Cell viability was evaluated via a methyl-thiazolyl-tetrazolium-bromide (MTT, Sigma, USA) 
assay.this method is based on the ability of living cells in converting soluble tetrazolium salt to 
insoluble formazan. To perform the test, the cells were passaged twice and were then transferred to a 
96-well plate, wherein 10 ml of MTT solution (5 mg/ml in PBS) was added to each well containing 
100 ml of cultured medium. The dissolved, yellowish MTT is converted to an insoluble purple 
formazan by cleavage of the tetrazolium ring via dehydrogenase enzymes during 4 hours of 
incubation. The produced, insoluble formazan was dissolved in a solution containing 100 ml iso-
propanol (Merck, Germany) and its optical density (OD) was read against a blank reagent with a 
multi-well scanning spectrophotometer at a wavelength of 570 nm. Untreated cells were used as 
control. 
The percentage of cytotoxicity was calculated according to the following formulae: %𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 = 1 − mean absorbance of toxicant treated cells
𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚 𝑚𝑚𝑎𝑎𝑎𝑎𝑐𝑐𝑎𝑎𝑎𝑎𝑚𝑚𝑎𝑎𝑐𝑐𝑚𝑚 𝑐𝑐𝑜𝑜 𝑎𝑎𝑚𝑚𝑛𝑛𝑚𝑚𝑐𝑐𝑐𝑐𝑛𝑛𝑚𝑚 𝑐𝑐𝑐𝑐𝑎𝑎𝑐𝑐𝑎𝑎𝑐𝑐𝑐𝑐 × 100 
                                    %Viability =100– % cytotoxity 
RNA Extraction by the TRIzol Reagent 
After incubation, cells were trypsinised and centrifuged for 5 min at 3000 rpm for the cells to 
pellet. The pellets were washed 2-3 times with sterile PBS for RNA isolation. In detail, 300 µL of 
the TRIzol solution was added to the cell pellet and was vortexed. The reaction mixture was 
incubated at room temperature (RT) for 5 minutes and then 80µL of chloroform was added while 
being thoroughly mixed. Then, the mixture was incubated at RT for 5 minutes, followed by 
centrifugation at 11,000 g for 15 minutes at 4°C. The aqueous phase was collected into a separate 
1.5 mL micro centrifuge tube and 150µL of isopropyl alcohol was added. The reaction mixture was 
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incubated at RT for 10 minutes followed by centrifugation at 13,000 rpm for 10 minutes at 4°C. 
RNA was then pelleted with 75% absolute alcohol and centrifuged at 9,000g for 10 minutes at 4°C. 
The pellets were air-dried and resuspended in 10µL of RNAase-free water for further use. 
REAL-TIME PCR Analysis 
The expression of apoptotic genes was analyzed by reverse transcription PCR via a one-step 
real-time SYBR Green mix. Relevant mRNA levels of two apoptotic genes were tested using the 
reference gene GAPDH to normalize the gene expression. Quantitative real-time RT-PCR was 
performed in a reaction volume of 25µL according to the manufacturer’s instructions. Briefly, 13µL 
of master mix, 0.2µL of primer (0.2nM) and 5µL of template RNA (100µg) were added to 0.2mL 
PCR tubes. After a brief centrifugation, the PCR plate was subjected to 30 cycles using the 
following conditions for cDNA: 50°C for 10 minutes (i) PCR activation at 95°C for 5 min; (ii) 
denaturation at 95°C for 5s; and (iii) annealing/extension at 60°C for 10 s. The quantitative RT-PCR 
data were analyzed using the comparative threshold (Ct) method. GAPDH was used as an internal 
reference gene to normalize the expression of the apoptotic genes. The Ct cycle was used to 
determine the expression level in MCF-7 cells treated with silibinin for 48 hours. Sequences of 
primers that were used are listed in Table 1. 
Table 1: Sequences of primers used 
Gene Forward primer (5'–3') Reverse primer (5'–3') Size (bp) 
Bax CGAGAGGTCTTTTTCCGAGTG GTGGGCGTCCCAAAGTAGG 242 
Bcl-2 CGGTGGGGTCATGTGTGTG CGGTTCAGGTACTCAGTCATCC 90 
GAPDH GAAGGTGAAGGTCGGAGTC GAAGATGGTGATGGGATTTC 226 
Statistical analysis 
The statistical software (SPSS 19) was used for data analysis. The student t-test and ANOVA 
were applied to interpret the data pertaining to the different silibinin treatments to evaluate the 
differences between control groups and treated samples. 
Results 
Silibinin Cytotoxicity on MCF-7 cells 
Cell survival was evaluated by the MTT assay which showed that silibinin impedes the 
growth of MCF-7 cells in a manner that is dependent on dosage and time (Fig. 1). 
 
Figure 1. Evaluation of silibinin inhibitory effects on cell proliferation by the MTT assay 
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In order to check the inhibition activity of silibinin, MCF-7 cells were plated and treated with 
different concentrations of silibinin (50µl, 100 µl and 200 µl) (Table 1). The MTT assay was 
performed after 12, 24 and 48 hours following the silibinin treatment. 
Figure 1 shows the relative difference in cell survival, resulting from the 3 separate schedules 
pertinent to each concentration of silibinin, drawn against the control group. 
As results show in figure 1, the inhibitory activity was measured based on cell number. 
According to the results in Table 2, the cytotoxic effect of silibinin on cancer cells and their growth 
depends on dose and time. 
Table 2: Comparison between the means of effects of silibinin on cell viability 
Variable 
time 
Silibinin concentration (µl) 
50 100 200 0 
12 hr 78b٭ 58c 42d 100a 
24 hr 58c 65b 37d 100a 
48 hr 35b 32b 16c 100a 
٭Different letters in each row represent significance by the Duncan test at p<0.05 
According to the diagram, when the cancer cells are treated with silibinin for longer 
durations, the growth rate declines correspondingly. Higher doses of silibinin prevent cell growth 
more effectively. Therefore the effect of silibinin concentration could remarkably alter the outcome 
of cell growth.   
The most toxic concentration of silibinin on MFC-7 cells was 200 µl after 48 hours of 
exposure. Statistically, silibinin significantly decreased cell viability in all treatments (F3, 35 = 
697.83 P<0.001) and as regards the duration of exposure (F2, 35 = 179.03 P<0.001). However, the 
magnitude of this decrease in cell viability was different among various combinations of duration × 
concentration (F6, 35 = 29.91 P<0.001). Treating the cancer cells with 200 µl of silibinin resulted in 
the greatest decrease in cell viability, which is when the cells were exposed to silibinin for 48 hours.  
Silibinin’s effect on the expression of apoptotic genes 
To investigate the molecular mechanism of silibinin-induced apoptosis in MCF-7 cells, the 
expression levels of two apoptosis-related genes were examined. To evaluate the effect of silibinin 
on the expression of the Bax and the BCL 2 genes, the expressions of these two genes were analyzed 
by real-time PCR. 
The Bax protein is known to be a key protein involved in apoptosis induced by various 
factors, and its role is to act in the internal apoptosis path. To investigate the effect of silibinin on 
BCL 2 and Bax genes, their expressions of mRNA were analyzed by Real time PCR. Silibinin was 
observed to increase the level of Bax mRNA expression significantly, while it had no significant 
effect on the expression of the BCL-2 gene. 
Discussion 
Breast cancer is the most common malignant type of cellular proliferation in women 
worldwide and the incidence of this disease is increasing in a diverse array of countries. Among the 
causes of cancer, there are numerous factors that are progressing towards dangerous edges such as 
air pollution, stress, diet and lifestyle. It is known that the consumption of foods, which have 
antioxidant properties, can prevent cancer or reduce the risk of its occurrence (Ren et al, 2003; . 
Sylvester and Shah, 2002). Among the many food supplements of interest, in relation to this context, 
one can point to the extract of Silybum marianum. Recent studies on the anticancer effects of this 
plant extract have been successful, at least to some extent. 
The objective of this project was to investigate the effect of silibinin concentration on breast 
cancer cells, i.e. cell line MCF-7. Results show that these cells are notably sensitive to silibinin, 
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owing to the changes in apoptotic gene expressions. Silibinin’s inhibitory effect was dose-dependent 
and time-dependent. Our findings showed that the mechanisms of silibinin’s potential inhibitory 
effect on MCF-7 cells are to decrease cell proliferation and increase apoptosis of the cell. 
Our results showed that the most toxic concentration of silibinin occurs at 200 µl in 48 hours. 
Also, there is a significant difference between the dose and the duration of exposure when 
comparing treated cells with control cells (p<0.001). 
BCL-2 and Bax are two major proteins that are generally involved in apoptosis. The mRNA 
levels were performed using a one-step RT-PCR SYBR Green mix quantitative real-time reverse 
transcription PCR. 
The results indicate that silibinin significantly increases the level of Bax mRNA expression, 
while there was no effect on the expression of BCL-2. These findings confirm previous ones 
regarding other types of cancer with evidence of silibinin’s effectiveness and its impact on apoptotic 
genes. 
In a study conducted by Zhang et al (2012), it was found that silibinin inhibits the growth of 
gastric cancer SGC-7901 cells by reducing the expression of the protein p34cdc2 . Liu et al (2011) 
studied the inhibitory effects of silymarin on a highly metastatic lung cancer cell line Anip973 and 
found that silymarin exerts a significant inhibitory effect on the proliferation of Anip973 cells in a 
temporally and dose-dependent manner. It has also been found that the silymarin can further induce 
apoptosis. Miscellaneous studies have demonstrated the strong inhibitory effect of silibinin as it 
displays anti-growth properties and as it exerts apoptotic effects on different cell lines (Singh & 
Agarwal, 2004).  Results show the potent effect of silibinin on apoptotic genes and also on related 
processes in cells treated in experiments, compared to untreated cells or controls. Further studies 
shall be needed to determine the precise molecular mechanisms in this regard. 
In summary, the results of this study confirm the efficacy of the herbal supplement silibinin, 
its pro-apoptotic properties against breast cancer cell lines MFC-7. Prospects are in close reach that 
by using this herbal supplement, the human food diet may become purposefully effective in 
reducing breast cancer. 
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